We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$14.1B
AUM Growth
-$90M
Cap. Flow
-$394M
Cap. Flow %
-2.79%
Top 10 Hldgs %
21.48%
Holding
1,980
New
111
Increased
767
Reduced
962
Closed
123

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.3M
2
AAPL icon
Apple
AAPL
+$12.5M
3
LVS icon
Las Vegas Sands
LVS
+$10.1M
4
XOM icon
ExxonMobil
XOM
+$9.07M
5
ADP icon
Automatic Data Processing
ADP
+$7.98M

Sector Composition

Rank Sector Weight
1 Technology 28.17%
2 Healthcare 8.93%
3 Consumer Discretionary 8.08%
4 Financials 7.53%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
51
Merck
MRK
$314B
$48.8M 0.35%
394,358
-55,875
-12% -$7.2M
SBUX icon
52
Starbucks
SBUX
$119B
$48.2M 0.34%
619,456
+45,397
+8% +$3.7M
ISRG icon
53
Intuitive Surgical
ISRG
$133B
$46.2M 0.33%
103,944
+5,803
+6% +$2.31M
VZ icon
54
Verizon
VZ
$198B
$46.2M 0.33%
1,119,323
+54,443
+5% +$2.19M
INTC icon
55
Intel
INTC
$457B
$45.9M 0.33%
1,482,694
-43,656
-3% -$1.43M
REGN icon
56
Regeneron Pharmaceuticals
REGN
$78.5B
$45.8M 0.32%
43,592
+2,239
+5% +$2.17M
NOW icon
57
ServiceNow
NOW
$119B
$45M 0.32%
285,900
-11,315
-4% -$1.66M
UNP icon
58
Union Pacific
UNP
$172B
$44.7M 0.32%
197,443
+945
+0.5% +$221K
MDT icon
59
Medtronic
MDT
$110B
$44M 0.31%
558,425
+26,403
+5% +$2.16M
SYY icon
60
Sysco
SYY
$39.4B
$42.5M 0.3%
594,753
+33,853
+6% +$2.53M
LLY icon
61
Eli Lilly
LLY
$991B
$42.1M 0.3%
46,548
-4,491
-9% -$3.59M
MCD icon
62
McDonald's
MCD
$191B
$41.7M 0.3%
163,637
-29,743
-15% -$7.89M
JNJ icon
63
Johnson & Johnson
JNJ
$608B
$41.7M 0.3%
285,275
-1,398
-0.5% -$208K
LOW icon
64
Lowe's Companies
LOW
$117B
$41.4M 0.29%
187,925
-38,169
-17% -$8.71M
AEP icon
65
American Electric Power
AEP
$69.7B
$41.1M 0.29%
468,276
+21,467
+5% +$1.88M
ADP icon
66
Automatic Data Processing
ADP
$108B
$40.8M 0.29%
171,134
+32,487
+23% +$7.98M
ZTS icon
67
Zoetis
ZTS
$32.5B
$40.4M 0.29%
233,091
-74
-0% -$12.3K
PFE icon
68
Pfizer
PFE
$142B
$40M 0.28%
1,430,580
-41,646
-3% -$1.15M
SNPS icon
69
Synopsys
SNPS
$74.7B
$39.3M 0.28%
66,055
+10,196
+18% +$5.77M
NEE icon
70
NextEra Energy
NEE
$180B
$38.4M 0.27%
541,799
+4,402
+0.8% +$312K
PG icon
71
Procter & Gamble
PG
$337B
$38.1M 0.27%
230,946
-22,888
-9% -$3.74M
DLR icon
72
Digital Realty Trust
DLR
$71.1B
$37.4M 0.27%
246,143
-12,100
-5% -$1.74M
DE icon
73
Deere & Co
DE
$165B
$37.2M 0.26%
99,585
-1,462
-1% -$570K
SRLN icon
74
State Street Blackstone Senior Loan ETF
SRLN
$5.31B
$36.1M 0.26%
863,450
-19,385
-2% -$812K
BLK icon
75
Blackrock
BLK
$172B
$35.9M 0.25%
45,571
+1,795
+4% +$1.4M

Similar funds

Guggenheim Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Guggenheim Capital held 1,980 positions worth $14.1B, down 0.63% from $14.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Guggenheim Capital's Q2 2024 filing shows 111 new, 767 increased, 962 reduced and 123 closed positions. Its largest new stake was Arm: 48,961 shares worth $8.01M. The largest sale was VanEck Gold Miners ETF, an estimated $46.2M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Guggenheim Capital's largest Q2 2024 buy was Arm: 48,961 shares worth $8.01M.
  • Guggenheim Capital added most to Microsoft in Q2 2024, an estimated $17.3M increase.
  • Guggenheim Capital's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $19.6M.
  • Guggenheim Capital fully exited VanEck Gold Miners ETF in Q2 2024, selling an estimated $46.2M.
  • Guggenheim Capital's ten largest holdings make up 21% of its $14.1B portfolio in Q2 2024.
  • Guggenheim Capital opened 111 new positions and closed 123 in Q2 2024.
  • Guggenheim Capital's portfolio value fell 0.63% quarter-over-quarter to $14.1B.

Based on Guggenheim Capital's 13F filing for Q2 2024, filed 14 Aug 2024.